Qingyi (Anita) Wu

Qingyi (Anita) Wu has extensive work experience in the pharmaceutical industry. Qingyi (Anita) is currently serving as the Chief Commercial Officer at Dizal Pharmaceutical since October 2021. Previously, they held the position of Chief Commercial Officer at BeiGene from June 2019 to September 2021.

Prior to that, Wu worked at Sanofi as the BU GM Specialty Care, Sanofi China from August 2015 to June 2019. Qingyi (Anita) also served as the Executive Director of Diabetes BU, Regional Sales Director of Oncology and CNS BU, and Marketing Director of Oncology and CNS BU at AstraZeneca between 2011 and 2015.

Before joining AstraZeneca, Wu worked at Genzyme Genetics as the Director of New Product Development and Biosurgery BU from May 2010 to October 2011. Qingyi (Anita) also held various managerial positions at Pfizer Inc, including Senior Regional Marketing Manager of Oncology and Sr. Marketing Manager of Oncology BU in Pfizer China, from 2006 to 2010.

Wu started their career at Eli Lilly China as the Group Product Manager of Diabetes from March 1999 to February 2006. Qingyi (Anita) began their professional journey at Bayer Healthcare Company as the Market Research Supervisor of OTC Division from November 1996 to March 1999.

Qingyi (Anita) Wu completed their Bachelor's degree in Environmental Monitoring at Shanghai University from 1992 to 1996.